BrightFocus Foundation held this Access Live Event to speak with listeners about aging and driving. The event featured Elin Schold Davis from the Older Driver Initiative, who provided information about diseases that cause vision issues or loss and the effects on driving. Many participants had questions and concerns about safe driving conditions, signs for concerns about driving, and how to transition to driving less.

Safety And The Older Driver (May 2021)

The BrightFocus Foundation hosted this Access Live event to discuss AREDS2. The event featured Emily Chew, MD, Director of the Division of Epidemiology and Clinical Applications at the National Eye Institute. Dr. Chew shared the latest news on the role of nutritional supplements in age-related macular degeneration. Participants asked questions about how to know if they are purchasing the correct supplements and if AREDS2 can reverse vision damage.

AMD The Latest Results From The AREDS2 Study (June 2021)

BrightFocus Foundation hosted this Access Live event entitled “AMD: Your Questions Answered.” The event featured Joshua Dunaief, M.D., Ph.D., who provided an overview of Age-related Macular Degeneration (AMD) including prevention and treatment. There was specific discussion about overall vision health, new therapies, and which populations are more susceptible to AMD.

AMD Your Questions Answered (July 2021)

BrightFocus Foundation hosted this Access Live event entitled “What’s Ahead for AMD-Gene Therapy.” The event featured Arshad M. Khanani, MD, who provided an overview of Age-related Macular Degeneration (AMD) including an explanation on how gene therapy is being utilized. There was specific discussion about overall vision health, new therapies, and which populations are most susceptible to AMD.

Update On Gene Therapy For AMD Sept 2021

BrightFocus Foundation hosted this Access Live event, which featured experts including Moshe Vardi, Vice President and Global Medicine Team Lead at Alexion Pharmaceuticals, and Aleksandar Skuban, MD, Executive Medical Director for Neurology and Ophthalmology Clinical Development and Translational Sciences at Alexion Pharmaceuticals, Inc. Dr. Vardi explained the role of the immune system as it relates to GMD, or geographical atrophy. Dr. Skuban talked about studies being done to determine efficacy of new treatments, including Danicopan, for GMD.

Geographic Atrophy A Possible New Treatment Oct 2021

BrightFocus Foundation is a nonprofit organization supporting research and providing public education to help eradicate brain and eye diseases, including Alzheimer's disease, macular degeneration, and glaucoma. We are working to save mind and sight.

BrightFocus is at the forefront of brain and eye health, advancing early-stage, investigator-initiated research around the world. We also provide free educational materials to people affected by or interested in these diseases, empowering them to take action for themselves and others. They can take advantage of news and research results offered through BrightFocus websites, publications, social media, videos, podcasts, and TV and radio public service announcements. 